| Description |
1 online resource : color illustrations |
| Summary |
"The latest guidelines for cervical cancer screening by the American Society of Colposcopy and Cervical Pathology (ASCCP) was published in 2012. The new ASCCP risk-based management consensus guidelines are under development and are scheduled for publication in 2020. According to the US Preventative Services Task Force, the most recent recommendations (which apply to individuals who have a cervix, regardless of their sexual history or HPV vaccination status; not applicable to individuals who have been diagnosed with a high-grade precancerous cervical lesion or cervical cancer, individuals with in utero exposure to diethylstilbestrol, or those who have a compromised immune system) as of August 2018 include Recommend against screening for cervical cancer in women younger than 21 years Recommend screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years Recommend screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting) for women aged 30 to 65 years Recommend against screening for cervical cancer"-- Provided by publisher |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from digital title page (viewed on March 12, 2021) |
| Subject |
Cytodiagnosis.
|
|
Diagnosis, Differential.
|
|
Pathology, Cellular.
|
|
Cytodiagnosis
|
|
Diagnosis, Differential
|
|
Cytodiagnosis
|
|
Diagnosis, Differential
|
|
Pathology, Cellular
|
| Form |
Electronic book
|
| Author |
Park, Ji-Weon, editor.
|
|
Gattuso, Paolo, editor.
|
|
Reddy, Vijaya B., editor.
|
|
Masood, Shahla, editor.
|
| LC no. |
2020047657 |
| ISBN |
9781108907422 |
|
1108907423 |
|
